| - GRCh37:
- Chr16:87935517
- GRCh38:
- Chr16:87901911
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:87969974
- GRCh38:
- Chr16:87936368
| CA5A | M28K | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935498-87938530
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely pathogenic (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960334-87960571
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936072
- GRCh38:
- Chr16:87902466
| CA5A | V172M | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960411
- GRCh38:
- Chr16:87926805
| CA5A | I95V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925459
- GRCh38:
- Chr16:87891853
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jan 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925468
- GRCh38:
- Chr16:87891862
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960372
- GRCh38:
- Chr16:87926766
| CA5A | D108N | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Dec 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921736
- GRCh38:
- Chr16:87888130
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936063
- GRCh38:
- Chr16:87902457
| CA5A | N175D | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925447
- GRCh38:
- Chr16:87891841
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935578
- GRCh38:
- Chr16:87901972
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not provided | Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87925532
- GRCh38:
- Chr16:87891926
| CA5A | D216A | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925480
- GRCh38:
- Chr16:87891874
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921866
- GRCh38:
- Chr16:87888260
| CA5A | R263C | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960529
- GRCh38:
- Chr16:87926923
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925469
- GRCh38:
- Chr16:87891863
| CA5A | P237L | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925536
- GRCh38:
- Chr16:87891930
| CA5A | F215I | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Inborn genetic diseases | Uncertain significance (Apr 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87960516
- GRCh38:
- Chr16:87926910
| CA5A | G60R | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935535
- GRCh38:
- Chr16:87901929
| CA5A | P201T | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921786
- GRCh38:
- Chr16:87888180
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925392
- GRCh38:
- Chr16:87891786
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935508
- GRCh38:
- Chr16:87901902
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87969980
- GRCh38:
- Chr16:87936374
| CA5A | R26H | CA5A-related condition, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Mar 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87925543
- GRCh38:
- Chr16:87891937
| CA5A | M212I | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938422
- GRCh38:
- Chr16:87904816
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Apr 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938381
- GRCh38:
- Chr16:87904775
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925515
- GRCh38:
- Chr16:87891909
| CA5A | P222S | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Jul 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936089
- GRCh38:
- Chr16:87902483
| CA5A | N166S | Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Conflicting interpretations of pathogenicity (Dec 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:87936076
- GRCh38:
- Chr16:87902470
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Dec 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936140
- GRCh38:
- Chr16:87902534
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938385
- GRCh38:
- Chr16:87904779
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921801
- GRCh38:
- Chr16:87888195
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936073
- GRCh38:
- Chr16:87902467
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921768
- GRCh38:
- Chr16:87888162
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Nov 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960509
- GRCh38:
- Chr16:87926903
| CA5A | T62I | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Dec 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925496
- GRCh38:
- Chr16:87891890
| CA5A | W228* | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Pathogenic (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960439
- GRCh38:
- Chr16:87926833
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938464
- GRCh38:
- Chr16:87904858
| CA5A | F129L | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960545
- GRCh38:
- Chr16:87926939
| CA5A | P50Q | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not specified | Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87925405
- GRCh38:
- Chr16:87891799
| CA5A | Q258H | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960507
- GRCh38:
- Chr16:87926901
| CA5A | R63W | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936078
- GRCh38:
- Chr16:87902472
| CA5A | A170S | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921871
- GRCh38:
- Chr16:87888265
| CA5A | A261V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938447
- GRCh38:
- Chr16:87904841
| CA5A | A135V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925561-87970113
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely pathogenic (Aug 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925549
- GRCh38:
- Chr16:87891943
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921865
- GRCh38:
- Chr16:87888259
| CA5A | R263H | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:87935548
- GRCh38:
- Chr16:87901942
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jan 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925426
- GRCh38:
- Chr16:87891820
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936019
- GRCh38:
- Chr16:87902413
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938413
- GRCh38:
- Chr16:87904807
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jun 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938382
- GRCh38:
- Chr16:87904776
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Oct 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960338
- GRCh38:
- Chr16:87926732
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921876
- GRCh38:
- Chr16:87888270
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Sep 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960347
- GRCh38:
- Chr16:87926741
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925567
- GRCh38:
- Chr16:87891961
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921807
- GRCh38:
- Chr16:87888201
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925453
- GRCh38:
- Chr16:87891847
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (May 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87970039
- GRCh38:
- Chr16:87936433
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960441
- GRCh38:
- Chr16:87926835
| CA5A | V85F | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935580
- GRCh38:
- Chr16:87901974
| CA5A | L186V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87970019
- GRCh38:
- Chr16:87936413
| CA5A | S13F | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938418
- GRCh38:
- Chr16:87904812
| CA5A | V145M | Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87936072
- GRCh38:
- Chr16:87902466
| CA5A | V172L | Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Conflicting interpretations of pathogenicity (Mar 2, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:87936042
- GRCh38:
- Chr16:87902436
| CA5A | V182M | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Oct 20, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87938475
- GRCh38:
- Chr16:87904869
| CA5A | L126V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925435
- GRCh38:
- Chr16:87891829
| CA5A | Q248H | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925556
- GRCh38:
- Chr16:87891950
| CA5A | A208V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960530
- GRCh38:
- Chr16:87926924
| CA5A | P55L | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938407
- GRCh38:
- Chr16:87904801
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960334-87970056
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Pathogenic (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87969934
- GRCh38:
- Chr16:87936328
| CA5A | W41C | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925553
- GRCh38:
- Chr16:87891947
| CA5A | R209Q | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Nov 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935521
- GRCh38:
- Chr16:87901915
| CA5A | H205Q | Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Mar 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87938439
- GRCh38:
- Chr16:87904833
| CA5A | E138K | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Dec 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925511
- GRCh38:
- Chr16:87891905
| CA5A | T223N | Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87938406
- GRCh38:
- Chr16:87904800
| CA5A | A149T | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Inborn genetic diseases | Uncertain significance (Jul 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87921805-87921806
- GRCh38:
- Chr16:87888199-87888200
| CA5A | P283E | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Sep 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938405
- GRCh38:
- Chr16:87904799
| CA5A | A149V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Sep 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925416
- GRCh38:
- Chr16:87891810
| CA5A | A255T | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960396
- GRCh38:
- Chr16:87926790
| CA5A | Y100N | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Sep 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960459
- GRCh38:
- Chr16:87926853
| CA5A | Q79E | Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (May 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87969968
- GRCh38:
- Chr16:87936362
| CA5A | P30R | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960407
- GRCh38:
- Chr16:87926801
| CA5A | W96S | not provided, Inborn genetic diseases, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency
| Uncertain significance (Mar 2, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87921834
- GRCh38:
- Chr16:87888228
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (May 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87960558-87960559
- GRCh38:
- Chr16:87926952-87926953
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87921804
- GRCh38:
- Chr16:87888198
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Oct 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925489
- GRCh38:
- Chr16:87891883
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938372-87960571
| CA5A | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Pathogenic (Mar 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87636753-88505740
| BANP, CA5A, JPH3, KLHDC4, SLC7A5, ZNF469 | | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Pathogenic (Oct 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87936074
- GRCh38:
- Chr16:87902468
| CA5A | V171A | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935561
- GRCh38:
- Chr16:87901955
| CA5A | T192M | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Oct 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87938424
- GRCh38:
- Chr16:87904818
| CA5A | H143D | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925550
- GRCh38:
- Chr16:87891944
| CA5A | A210V | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:87935556
- GRCh38:
- Chr16:87901950
| CA5A | Q194* | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:87925392-87925412
- GRCh38:
- Chr16:87891786-87891806
| CA5A | | not provided, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not specified
| Conflicting interpretations of pathogenicity (Apr 14, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:87936113
- GRCh38:
- Chr16:87902507
| CA5A | H158P | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, not provided | Uncertain significance (Aug 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:87960423
- GRCh38:
- Chr16:87926817
| CA5A | S91P | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |